請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27797
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 詹長權 | |
dc.contributor.author | Hui-Ju Yang | en |
dc.contributor.author | 楊惠如 | zh_TW |
dc.date.accessioned | 2021-06-12T18:21:06Z | - |
dc.date.available | 2009-09-12 | |
dc.date.copyright | 2007-09-12 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-08-22 | |
dc.identifier.citation | 1. Department of Health T. Health Statistics; assess at http://www.doh.gov.tw/statistic/index.htm.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365(9455):217-23. 3. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med 2000;342(1):1-8. 4. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335(8693):827-38. 5. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004;164(19):2113-8. 6. Harrison TR, Braunwald E. Harrison's principles of internal medicine. 16 ed McGraw-Hill, Medical Pub. Division, 2005. 7. Kaplan NM, Opie LH. Controversies in hypertension. Lancet 2006;367(9505):168-76. 8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr., Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206-52. 9. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Incidence of hypertension and risk of cardiovascular events among ethnic Chinese: report from a community-based cohort study in Taiwan. J Hypertens 2007;25(7):1355-1361. 10. Chiu YH, Wu SC, Tseng CD, Yen MF, Chen TH. Progression of pre-hypertension, stage 1 and 2 hypertension (JNC 7): a population-based study in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 9). J Hypertens 2006;24(5):821-8. 11. Dockery DW, Pope CA, 3rd, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Jr., Speizer FE. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329(24):1753-9. 12. Krewski D, Burnett RT, Goldberg M, Hoover K, Siemiatycki J, Abrahamowicz M, White W. Reanalysis of the Harvard Six Cities Study, part I: validation and replication. Inhal Toxicol 2005;17(7-8):335-42. 13. Krewski D, Burnett RT, Goldberg M, Hoover K, Siemiatycki J, Abrahamowicz M, Villeneuve PJ, White W. Reanalysis of the Harvard Six Cities Study, part II: sensitivity analysis. Inhal Toxicol 2005;17(7-8):343-53. 14. Laden F, Neas LM, Dockery DW, Schwartz J. Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect 2000;108(10):941-7. 15. Schwartz J, Laden F, Zanobetti A. The concentration-response relation between PM(2.5) and daily deaths. Environ Health Perspect 2002;110(10):1025-9. 16. Pope CA, 3rd, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Heath CW, Jr. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 1995;151(3 Pt 1):669-74. 17. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med 2000;343(24):1742-9. 18. Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med 2007;356(5):447-58. 19. Abbey DE, Mills PK, Petersen FF, Beeson WL. Long-term ambient concentrations of total suspended particulates and oxidants as related to incidence of chronic disease in California Seventh-Day Adventists. Environ Health Perspect 1991;94:43-50. 20. Abbey DE, Nishino N, McDonnell WF, Burchette RJ, Knutsen SF, Lawrence Beeson W, Yang JX. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med 1999;159(2):373-82. 21. Wong TW, Tam WS, Yu TS, Wong AHS. Associations between daily mortalities from respiratory and cardiovascular diseases and air pollution in Hong Kong, China. Occupational Environmental Medcine 2002;59:30-5. 22. Huang SL, Cheng WL, Lee CT, Huang HC, Chan CC. Contribution of endotoxin in macrophage cytokine response to ambient particles in vitro. J Toxicol Environ Health A 2002;65(17):1261-72. 23. Huang SL, Hsu MK, Chan CC. Effects of submicrometer particle compositions on cytokine production and lipid peroxidation of human bronchial epithelial cells. Environ Health Perspect 2003;111(4):478-82. 24. Pope CA, 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. Jama 2002;287(9):1132-41. 25. Villeneuve PJ, Goldberg MS, Krewski D, Burnett RT, Chen Y. Fine particulate air pollution and all-cause mortality within the Harvard Six-Cities Study: variations in risk by period of exposure. Ann Epidemiol 2002;12(8):568-76. 26. Goodman PG, Dockery DW, Clancy L. Cause-specific mortality and the extended effects of particulate pollution and temperature exposure. Environ Health Perspect 2004;112(2):179-85. 27. Clancy L, Goodman P, Sinclair H, Dockery DW. Effect of air-pollution control on death rates in Dublin, Ireland: an intervention study. Lancet 2002;360(9341):1210-4. 28. Laden F, Schwartz J, Speizer FE, Dockery DW. Reduction in fine particulate air pollution and mortality: Extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med 2006;173(6):667-72. 29. Dockery DW. Epidemiologic evidence of cardiovascular effects of particulate air pollution. Environ Health Perspect 2001;109 Suppl 4:483-6. 30. Cheng TJ, Hwang JS, Wang PY, Tsai CF, Chen CY, Lin SH, Chan CC. Effects of concentrated ambient particles on heart rate and blood pressure in pulmonary hypertensive rats. Environ Health Perspect 2003;111(2):147-50. 31. Lei YC, Chan CC, Wang PY, Lee CT, Cheng TJ. Effects of Asian dust event particles on inflammation markers in peripheral blood and bronchoalveolar lavage in pulmonary hypertensive rats. Environ Res 2004;95(1):71-6. 32. Lei YC, Hwang JS, Chan CC, Lee CT, Cheng TJ. Enhanced oxidative stress and endothelial dysfunction in streptozotocin-diabetic rats exposed to fine particles. Environ Res 2005;99(3):335-43. 33. Hwang J-S, Hu T-H, Chan C-C. Air Pollution Mix and Emergency Room Visits for Respiratory and Cardiac Diseases in Taipei. Journal of Data Science 2004;2:311-327. 34. Chan CC, Chuang KJ, Shiao GM, Lin LY. Personal exposure to submicrometer particles and heart rate variability in human subjects. Environ Health Perspect 2004;112(10):1063-7. 35. Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. Effects of air pollution on blood pressure: a population-based approach. Am J Public Health 2001;91(4):571-7. 36. Ibald-Mulli A, Timonen KL, Peters A, Heinrich J, Wolke G, Lanki T, Buzorius G, Kreyling WG, de Hartog J, Hoek G, ten Brink HM, Pekkanen J. Effects of particulate air pollution on blood pressure and heart rate in subjects with cardiovascular disease: a multicenter approach. Environ Health Perspect 2004;112(3):369-77. 37. Peel JL, Metzger KB, Klein M, Flanders WD, Mulholland JA, Tolbert PE. Ambient air pollution and cardiovascular emergency department visits in potentially sensitive groups. Am J Epidemiol 2007;165(6):625-33. 38. Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 2002;105(13):1534-6. 39. Urch B, Silverman F, Corey P, Brook JR, Lukic KZ, Rajagopalan S, Brook RD. Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect 2005;113(8):1052-5. 40. Harrabi I, Rondeau V, Dartigues JF, Tessier JF, Filleul L. Effects of particulate air pollution on systolic blood pressure: A population-based approach. Environ Res 2006;101(1):89-93. 41. Lipfert FW, Perry HM, Jr., Miller JP, Baty JD, Wyzga RE, Carmody SE. Air pollution, blood pressure, and their long-term associations with mortality. Inhal Toxicol 2003;15(5):493-512. 42. Tarkiainen TH, Timonen KL, Vanninen EJ, Alm S, Hartikainen JE, Pekkanen J. Effect of acute carbon monoxide exposure on heart rate variability in patients with coronary artery disease. Clin Physiol Funct Imaging 2003;23(2):98-102. 43. de Paula Santos U, Braga AL, Giorgi DM, Pereira LA, Grupi CJ, Lin CA, Bussacos MA, Zanetta DM, do Nascimento Saldiva PH, Filho MT. Effects of air pollution on blood pressure and heart rate variability: a panel study of vehicular traffic controllers in the city of Sao Paulo, Brazil. Eur Heart J 2005;26(2):193-200. 44. Chou CCK, Liu SC, Lin CY, Shiu CJ, Chang KH. The trend of surface ozone in Taipei, Taiwan, and its causes: Implications for ozone control strategies. Atmospheric Environment 2006;40(21):3898-3908. 45. Tager IB, Balmes J, Lurmann F, Ngo L, Alcorn S, Kunzli N. Chronic exposure to ambient ozone and lung function in young adults. Epidemiology 2005;16(6):751-9. 46. Henrotin JB, Besancenot JP, Bejot Y, Giroud M. Short-term effects of ozone air pollution on ischaemic stroke occurrence: a case-crossover analysis from a 10-year population-based study in Dijon, France. Occup Environ Med 2007;64(7):439-45. 47. Chan CC, Wu TH. Effects of ambient ozone exposure on mail carriers' peak expiratory flow rates. Environ Health Perspect 2005;113(6):735-8. 48. Ruidavets JB, Cassadou S, Cournot M, Bataille V, Meybeck M, Ferrieres J. Increased resting heart rate with pollutants in a population based study. J Epidemiol Community Health 2005;59(8):685-93. 49. Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-Bengston E, Gates KA, Hartley LH, Suh H, Gold DR. Ambient pollution and blood pressure in cardiac rehabilitation patients. Circulation 2004;110(15):2184-9. 50. Hwang JS, Chan CC. Effects of air pollution on daily clinic visits for lower respiratory tract illness. Am J Epidemiol 2002;155(1):1-10. 51. Hoek G, Brunekreef B, Goldbohm S, Fischer P, van den Brandt PA. Association between mortality and indicators of traffic-related air pollution in the Netherlands: a cohort study. Lancet 2002;360(9341):1203-9. 52. Madsen C, Nafstad P. Associations between environmental exposure and blood pressure among participants in the Oslo Health Study (HUBRO). Eur J Epidemiol 2006;21(7):485-91. 53. DeZuane J. Handbook of Drinking Water Quality John Wiley & Sons, 1997. 54. Masironi R. Trace elements and cardiovascular diseases. Bull World Health Organ 1969;40(2):305-12. 55. WHO/IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans, assessed at http://monographs.iarc.fr/ENG/Classification/index.php. 56. Sauvant MP, Pepin D. Drinking water and cardiovascular disease. Food Chem Toxicol 2002;40(10):1311-25. 57. Rylander R, Bonevik H, Rubenowitz E. Magnesium and calcium in drinking water and cardiovascular mortality. Scand J Work Environ Health 1991;17(2):91-4. 58. Monarca S, Donato F, Zerbini I, Calderon RL, Craun GF. Review of epidemiological studies on drinking water hardness and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil 2006;13(4):495-506. 59. Yang CY, Chang CC, Tsai SS, Chiu HF. Calcium and magnesium in drinking water and risk of death from acute myocardial infarction in Taiwan. Environ Res 2006;101(3):407-11. 60. Yang CY. Calcium and magnesium in drinking water and risk of death from cerebrovascular disease. Stroke 1998;29(2):411-4. 61. Yang CY, Chiu HF. Calcium and magnesium in drinking water and the risk of death from hypertension. Am J Hypertens 1999;12(9 Pt 1):894-9. 62. Rosenlund M, Berglind N, Hallqvist J, Bellander T, Bluhm G. Daily intake of magnesium and calcium from drinking water in relation to myocardial infarction. Epidemiology 2005;16(4):570-6. 63. Yang CY. Relationship between trace metal concentrations and hardness in drinking water in Taiwan. Bull Environ Contam Toxicol 1999;63(1):59-64. 64. Chen TH, Chiu YH, Luh DL, Yen MF, Wu HM, Chen LS, Tung TH, Huang CC, Chan CC, Shiu MN, Yeh YP, Liou HH, Liao CS, Lai HC, Chiang CP, Peng HL, Tseng CD, Yen MS, Hsu WC, Chen CH. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 2004;100(8):1734-43. 65. RC L, GA M, WW S, RD W. SAS System for Mixed Models SAS Institute Inc, 1996. 66. Pan WH, Chang HY, Yeh WT, Hsiao SY, Hung YT. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996. J Hum Hypertens 2001;15(11):793-8. 67. 陳建仁, 游山林, 白其卉, 蘇大成, 曾慶孝, 簡國龍, 黃麗卿. 台灣地區高血糖、高血脂、高血壓盛行率調查. 2003. 68. Vargas CM, Ingram DD, Gillum RF. Incidence of hypertension and educational attainment: the NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol 2000;152(3):272-8. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27797 | - |
dc.description.abstract | 目的:透過收集飲用水品質及空氣品質等環境品質資料,與社區整合式篩檢之民眾個人資料,進行環境品質與高血壓相關性之研究。
材料與方法:研究族群為台灣81個社區81,949位20歲以上參與社區整合式篩檢之民眾(2001年至2005年)。高血壓依據美國國家高血壓預防、診斷、評估以及治療聯合委員會第七次報告建議之分類,收縮壓高於或等於140 毫米汞柱,或舒張壓高於或等於90 毫米汞柱者定義為高血壓個案。空氣品質資料為環保署空氣品質監測網之空氣品質測站資料,項目包括空氣中懸浮微粒(粒徑小於10微米)、二氧化氮、二氧化硫、一氧化碳、臭氧,資料收集期間為1993年至2005年。飲用水品質資料來源為台灣自來水公司之檢測資料,以及環保署毒管處之抽驗資料,項目包括硬度、酸鹼值、亞硝酸鹽、硝酸鹽、硫酸鹽,資料收集期間為1979年至2005年。統計模式採用具有隨機校應的廣義線性混合型模式,控制相關危險因子,包括性別、年齡、身體質量指數、抽菸、飲酒、運動習慣、家族病史、教育程度,探討環境品質與高血壓之關係。 結果:共計選取12個社區共18867為民眾為空氣品質研究社區,而飲用水品質則有81個社區共81949個民眾。12個空氣品質研究社區中,高血壓年齡標準化盛行率為23 %,而81個飲用水品質研究社區中之高血年齡標準盛行率為24 %。在個人危險因子方面,性別、年齡、身體質料指數、飲酒、低教育程度、家族病史、飯前血糖,在本研究中發現與高血壓有正相關。而抽菸、運動、高密度脂蛋白,在本研究中發現與高血壓有負相關。空氣品質中,二氧化硫(OR: 1.21, 1.12-1.29),懸浮微粒(PM10) (OR: 1.10, 1.06-1.15), 以及二氧化氮 (OR: 1.16, 1.08-1.25)與罹患高血壓有顯著正相關。而在飲水品質中,硝酸鹽 (OR: 0.91, 0.85-0.97),硫酸鹽(OR: 0.98, 0.98-0.99)以及總硬度(OR: 0.97, 0.96-0.98)則與罹患高血壓呈現顯著負相關。 結論:空氣品質中之二氧化硫、懸浮微粒以及二氧化氮與高血壓呈現正相關,而飲用水品質中的硝酸鹽、硫酸鹽、總硬度,則呈現負相關。確切的劑量反應和生物機轉需要後續的研究以釐清。 | zh_TW |
dc.description.abstract | Purpose: The purpose of this study is to investigate the association between hypertension and air and drinking water quality.
Material and methods: Our study population includes 81,949 residents over 20 years old of 81 communities who have participated in a community-based integrated screen programs for multiple diseases from 2001 to 2005 in Taiwan. The classification of participant’s hypertensive status is based on the JNC7 criteria. The air quality data in each community including particulate matter, nitrogen oxide, sulfur dioxide, carbon oxide, and ozone from 1993 to 2005 were obtained from the TEPA air pollutant monitor network. The quality of drinking water in each community including hardness (calcium carbonate), pH, nitrite, nitrate, and sulfate during 1979-2005 obtained from a routine monitoring program operated by the Taiwan Water Cooperation (TWC) and Taiwan Environmental Protection Agency (TEPA). We used Generalized Linear Mixed-effect models to investigate the association between hypertension and environmental quality items adjusted for gender, age, body mass index, smoking, drinking, exercise, education level and family history. Results: We collected 18867 subjects in 12 communities to study the association of air quality and hypertension, and 81949 subjects in 81 communities to study the association of drinking water quality and hypertension. The age adjusted prevalence rate averaged at 23 % among the 12 communities, and the age adjusted prevalence rate of hypertension averaged at 24 % among the 81 communities. In our study, we found the effects of these risk factors of hypertension as follows: gender, age, BMI, drinking, low educational level, hypertension family history, and glucose value showed the positive effects of hypertension; cigarette smoking, exercise behavior, and HDLC value showed negative effects. We found the positive effects of sulfur dioxide (OR: 1.21, 1.12-1.29), PM10 (OR: 1.10, 1.06-1.15), and nitrogen dioxide (OR: 1.16, 1.08-1.25) in air quality and the negative effects of nitrite (OR: 0.91, 0.85-0.97), sulfate (OR: 0.98, 0.98-0.99), and hardness (OR: 0.97, 0.96-0.98) in drinking water quality. Further multiple pollutants and gender difference analysis also showed similar results. Conclusion: Sulfur dioxide, particulate matter, and nitrogen dioxide in air quality are positively associated with hypertension, whereas nitrite, sulfate, and hardness are negatively associated with hypertension. Further studies can be performed to explore the dose response and biomechanism. | en |
dc.description.provenance | Made available in DSpace on 2021-06-12T18:21:06Z (GMT). No. of bitstreams: 1 ntu-96-R94841005-1.pdf: 711547 bytes, checksum: a33c75b2a8e0763d37e1011e774de15b (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | I Introduction 1
1.1 The Studies of Hypertension 1 1.2 The Health Effects of Environmental Quality 5 1.2.1 Air Quality 5 Particulate Matter 5 Carbon Monoxide 10 Ozone 10 Sulfur Dioxide 11 Nitrogen Dioxide 12 1.2.2 Drinking Water Quality 13 Hardness 14 II Material and Method 15 2.1 Study Framework 15 2.2 Study Population 16 2.2.1 Definition and Measurements of Blood pressure 24 2.2.2 Individual Risk Factors 25 2.3 Air Quality 26 2.4 Drinking Water Quality 27 2.5 Data Analysis 28 III. Results 32 3.1 Air Quality 32 3.1.1 The air pollutants’ concentration in the 12 air quality communities 32 3.1.2 The distribution of individual risk factors in the 12 air quality communities 35 3.1.3 The prevalence of hypertension in the 12 air quality sample communities 39 3.1.4 The model of hypertension and air quality 41 3.2 Drinking Water Quality 48 3.2.1 The drinking water pollutants concentration in the 81 water quality communities 48 3.2.2 The distribution of individual risk factors in the 81 water quality communities 53 3.2.3 The prevalence of hypertension in the 81 drinking water quality communities 67 3.2.4 The model of hypertension and drinking water quality 71 3.3 Multiple pollutants of air quality and drinking water quality 77 IV. Discussion 85 4.1 Air quality, drinking water quality and hypertension 85 4.2 Study limitations 94 4.3 Conclusion 96 V. Reference 97 VI. Appendixes 103 | |
dc.language.iso | en | |
dc.title | 空氣與飲用水品質與高血壓相關性之社區型研究 | zh_TW |
dc.title | A community-based study on the association between hypertension and the air and drinking water quality | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 王淑麗,蘇大成 | |
dc.subject.keyword | 空氣品質,飲用水品質,高血壓,廣義線性混合型模式, | zh_TW |
dc.subject.keyword | Air quality,drinking water quality,hypertension,Generalized Linear Mixed Model, | en |
dc.relation.page | 139 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-08-23 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 職業醫學與工業衛生研究所 | zh_TW |
顯示於系所單位: | 職業醫學與工業衛生研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 694.87 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。